Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
PGNY Progyny Inc
- Stocks
- Healthcare
- NASDAQ: PGNY
Price (delayed)
$21.3
Market cap
$1.83B
P/E Ratio
36.1
Dividend/share
N/A
EPS
$0.59
Enterprise value
$1.74B
Progyny is a leading fertility benefits management company in the US. The company is redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously
Highlights
Progyny's gross profit has increased by 10% YoY and by 5% QoQ
The revenue is up by 9% year-on-year and by 3.9% since the previous quarter
The stock's price to earnings (P/E) is 42% less than its 5-year quarterly average of 62.2 but 6% more than its last 4 quarters average of 34.2
PGNY's equity is down by 18% year-on-year but it is up by 11% since the previous quarter
The company's debt has surged by 58% QoQ and by 55% YoY
PGNY's quick ratio is down by 28% year-on-year and by 15% since the previous quarter
Key stats
What are the main financial stats of PGNY
Market
Valuations
Earnings
Shares outstanding
85.72M
Market cap
$1.83B
Enterprise value
$1.74B
Price to earnings (P/E)
36.1
Price to book (P/B)
3.89
Price to sales (P/S)
1.5
EV/EBIT
20.17
EV/EBITDA
19.37
EV/Sales
1.44
Revenue
$1.21B
Gross profit
$266.75M
Operating income
$73.1M
Net income
$52.5M
EBIT
$86.41M
EBITDA
$89.98M
Free cash flow
$195.78M
Per share
Balance sheet
Liquidity
EPS
$0.59
EPS diluted
$0.56
Free cash flow per share
$2.29
Book value per share
$5.47
Revenue per share
$14.19
TBVPS
$8.23
Total assets
$730.29M
Total liabilities
$263.13M
Debt
$26M
Equity
$467.16M
Working capital
$330.56M
Debt to equity
0.06
Current ratio
2.39
Quick ratio
2.34
Net debt/EBITDA
-0.93
Margins
Efficiency
Dividend
EBITDA margin
7.4%
Gross margin
22%
Net margin
4.3%
Operating margin
6%
Return on assets
7.8%
Return on equity
11.8%
Return on invested capital
24.7%
Return on capital employed
17.5%
Return on sales
7.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PGNY stock price
How has the Progyny stock price performed over time
Intraday
-3.09%
1 week
0.24%
1 month
-8.31%
1 year
-21.55%
YTD
23.48%
QTD
-4.66%
Financial performance
How have Progyny's revenue and profit performed over time
Revenue
$1.21B
Gross profit
$266.75M
Operating income
$73.1M
Net income
$52.5M
Gross margin
22%
Net margin
4.3%
The company's net margin fell by 22% YoY and by 9% QoQ
The net income has contracted by 14% YoY and by 3.4% from the previous quarter
Progyny's operating income has increased by 11% YoY and by 8% QoQ
Progyny's gross profit has increased by 10% YoY and by 5% QoQ
Price vs fundamentals
How does PGNY's price correlate with its fundamentals
Growth
What is Progyny's growth rate over time
Valuation
What is Progyny stock price valuation
P/E
36.1
P/B
3.89
P/S
1.5
EV/EBIT
20.17
EV/EBITDA
19.37
EV/Sales
1.44
The stock's price to earnings (P/E) is 42% less than its 5-year quarterly average of 62.2 but 6% more than its last 4 quarters average of 34.2
The EPS has declined by 9% year-on-year
PGNY's price to book (P/B) is 68% lower than its 5-year quarterly average of 12.1 and 10% lower than its last 4 quarters average of 4.3
PGNY's equity is down by 18% year-on-year but it is up by 11% since the previous quarter
PGNY's price to sales (P/S) is 74% lower than its 5-year quarterly average of 5.7 and 12% lower than its last 4 quarters average of 1.7
The revenue is up by 9% year-on-year and by 3.9% since the previous quarter
Efficiency
How efficient is Progyny business performance
PGNY's return on invested capital is up by 35% year-on-year and by 11% since the previous quarter
Progyny's return on assets has decreased by 6% YoY
The return on sales has grown by 2.9% year-on-year
The company's return on equity rose by 2.6% QoQ
Dividends
What is PGNY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PGNY.
Financial health
How did Progyny financials performed over time
PGNY's total assets is 178% more than its total liabilities
PGNY's total liabilities is up by 42% since the previous quarter and by 18% year-on-year
Progyny's current ratio has decreased by 28% YoY and by 15% QoQ
The company's debt is 94% lower than its equity
PGNY's debt to equity has surged by 100% year-on-year and by 50% since the previous quarter
The company's debt has surged by 58% QoQ and by 55% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.